Topic Contents
Vitamin A
Uses
Related Topics
Vitamin A is a fat-soluble vitamin with four major functions in the body: (1) It helps cells reproduce normally—a process called differentiation (cells that have not properly differentiated are more likely to undergo pre-cancerous changes). (2) It is required for vision; vitamin A maintains healthy cells in various structures of the eye and is required for the transduction of light into nerve signals in the retina. (3) It is required for normal growth and development of the embryo and fetus, influencing genes that determine the sequential development of organs in embryonic development. (4) It may be required for normal reproductive function, with influences on the function and development of sperm, ovaries and placenta.
What Are "Star" Ratings?
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.
Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.
For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.
This supplement has been used in connection with the following health conditions:
| Used for | Amount | Why |
|---|---|---|
|
Anemia and Vitamin A Deficiency
|
10,000 to 25,000 IU daily |
Vitamin A deficiency can contribute to anemia, supplementing with this vitamin may restore levels and improve symptoms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Childhood Diseases
|
High doses of vitamin A may be used to treat measles or chicken pox, but only under a doctor's supervision |
Vitamin A plays a critical role in proper immune function, it has been used successfully to prevent and treat measles and to treat chicken pox. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Cystic Fibrosis
|
5,000 to 10,000 IU daily |
The fat malabsorption associated with cystic fibrosis often leads to a deficiency of fat-soluble vitamins, such as vitamin A. Supplementing with this vitamin can help counteract the deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Infection
|
See a doctor for evaluation of possible deficiency |
Vitamin A plays an important role in immune system function and helps mucous membranes, including those in the lungs, resist invasion by microorganisms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Leukoplakia
|
28,500 IU daily under medical supervision |
Vitamin A has been shown to be effective against leukoplakia. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Measles and Vitamin A Deficiency
|
200,000 IU daily for two days under medical supervision |
In developing countries where vitamin A deficiency is common, preventive supplementation with vitamin A reduced the risk of death in children with measles. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Night Blindness
|
If deficient: 10,000 to 25,000 IU daily |
Night blindness may be an early sign of vitamin A deficiency. Doctors often recommend supplementing with vitamin A per day to correct a deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Celiac Disease and Vitamin A Deficiency
|
Consult a qualified healthcare practitioner |
Vitamin A deficiency may occur as a result of celiac disease, in which case vitamin A supplements or injections can be beneficial. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Heart Attack
|
50,000 IU daily |
Taking vitamin A may reduce heart attack risk and may improve the outcome for people who have already had a heart attack. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Immune Function
|
Consult a qualified healthcare practitioner |
Vitamin A plays an important role in immune system function and helps mucous membranes, including those in the lungs, resist invasion by microorganisms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Menorrhagia
|
50,000 IU of vitamin A each day taken under the supervision of a doctor |
In one study, women with menorrhagia who took vitamin A showed significant improvement or complete normalization of menstrual blood loss. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Peptic Ulcer
|
Take under medical supervision: 150,000 IU per day |
Vitamin A is needed to heal the linings of the stomach and intestines. In one trial, supplementing with vitamin A improved healing in a small group of people with stomach ulcer. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Severe Measles
|
Consult a qualified healthcare practitioner |
Two studies of children with severe measles showed that supplementing with high doses vitamin A speeded recovery and reduced complications and pneumonia-related deaths. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Wound Healing
|
Take under medical supervision: 25,000 IU daily |
Vitamin A plays a central role in wound healing and may be useful as a supplement or in a topical ointment. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Abnormal Pap Smear
|
Refer to label instructions |
Women who don’t get enough vitamin A have an increased risk of cervical dysplasia, though there is little research on using vitamin A as a treatment. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Acne Vulgaris
|
Refer to label instructions |
Under medical supervision, large quantities of vitamin A have been used successfully to treat severe acne. However, the acne typically returns after treatment is discontinued. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Alcohol Withdrawal
|
Refer to label instructions |
Because of potential liver damage, correcting the vitamin A deficiency common to alcoholics requires a doctor’s supervision to monitor liver function. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Conjunctivitis and Blepharitis
|
Refer to label instructions |
Vitamin A deficiency has been reported in people with chronic conjunctivitis, but it is unknown whether vitamin A supplementation can help the condition. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Crohn’s Disease
|
Refer to label instructions |
Vitamin A is needed for the growth and repair of cells that line both the small and large intestine and can improve symptoms in people with Crohn’s disease. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Diarrhea
|
Refer to label instructions |
Only in cases of malabsorption should vitamin A be used to treat diarrhea, as it has been shown to have no effect or to increase risk of diarrhea in well-nourished children. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Gastritis
|
Refer to label instructions |
Vitamin A appears to reduce ulcer size and pain in people with ulcers and may help treat gastritis. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Goiter
|
Refer to label instructions |
Vitamin A levels are lower in people with goiter than in those without. A combination of vitamin C, vitamin E, and beta-carotene prevented goiter formation in iodine-deficient conditions in some research. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
HIV and AIDS Support
|
Refer to label instructions |
Vitamin A deficiency is common in people with HIV infection, and low levels of the vitamin are associated with greater disease severity. Ask your doctor if vitamin A is right for you. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Hypothyroidism
|
Refer to label instructions |
People with hypothyroidism may have an impaired ability to convert beta-carotene to vitamin A. For this reason, some doctors suggest supplementing with vitamin A. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Pre- and Post-Surgery Health
|
Refer to label instructions |
Topical vitamin A may help speed wound healing and reduce scarring in patients taking corticosteroids, which typically slow wound healing. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Premenstrual Syndrome
|
Refer to label instructions |
Very high amounts of vitamin A have reduced PMS symptoms in some studies. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Sickle Cell Anemia
|
Refer to label instructions |
Sickle cell anemia patients tend to have low levels of antioxidants, which protect cells from oxygen-related damage. Supplementing with vitamin A may help correct a deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Type 1 Diabetes
(Selenium, Vitamin C, Vitamin E) |
Refer to label instructions |
A combination of the antioxidants selenium, vitamin A, vitamin C, and vitamin E has been shown to improve diabetic retinopathy. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Type 1 Diabetes and Diabetic Retinopathy
(Selenium, Vitamin C, Vitamin E) |
Refer to label instructions |
Antioxidant nutrients including selenium, vitamin A, vitamin C, and vitamin E may combat free radicals associated with diabetic retinopathy. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Type 2 Diabetes and Diabetic Neuropathy
(Selenium, Vitamin C, Vitamin E) |
Refer to label instructions |
A combination of the antioxidants selenium, vitamin A, vitamin C, and vitamin E has been shown to improve diabetic retinopathy. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Urinary Tract Infection
|
Refer to label instructions |
Vitamin A deficiency increases the risk of many infection, supplementing with it may restore levels and help support the immune system. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Vaginitis
|
Refer to label instructions |
Some doctors recommend vaginal administration of vitamin A to improve the integrity of the vaginal tissue and to enhance the function of local immune cells. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Sunburn
(Vitamin D) |
Refer to label instructions | |
SunburnAntioxidants may protect the skin from sunburn due to free radical–producing ultraviolet rays.155 Combinations of 1,000 to 2,000 IU per day of vitamin E and 2,000 to 3,000 mg per day of vitamin C, but neither given alone, have a significant protective effect against ultraviolet rays, according to double-blind studies.156 , 157 , 158 Oral synthetic beta-carotene alone was not found to provide effective protection when given in amounts of 15 mg per day or for only a few weeks’ time in larger amounts of 60 to 90 mg per day, but it has been effective either in very large (180 mg per day) amounts or in smaller amounts (30 mg per day) in combination with topical sunscreen.159 , 160 , 161 , 162 , 163 Natural sources of beta-carotene or other carotenoids have been more consistently shown to protect against sunburn. One controlled study found that taking a supplement of natural carotenoids (almost all of which was beta-carotene) in daily amounts of 30 mg, 60 mg, and 90 mg gave progressively more protection against ultraviolet rays.164 In another controlled study, either 24 mg per day of natural beta-carotene or 24 mg per day of a carotenoid combination of equal amounts beta-carotene, lutein, and lycopene helped protect skin from ultraviolet rays.165 A preliminary study compared synthetic lycopene (10.1 mg per day), a natural tomato extract containing 9.8 mg of lycopene per day plus additional amounts of other carotenoids, and a solubilized tomato drink (designed to increase lycopene absorption) containing 8.2 mg of lycopene plus additional amounts of other carotenoids. After 12 weeks, only the two tomato-based products were shown to give significant protection against burning by ultraviolet light.166 Still other trials have tested combinations of several antioxidants. One preliminary study found that a daily combination of beta-carotene (6 mg), lycopene (6 mg), vitamin E (15 IU), and selenium for seven weeks protected against ultraviolet light.167 However, a double-blind trial of a combination of smaller amounts of several carotenoids, vitamins C and E, selenium, and proanthocyanidins did not find significant UV protection compared with placebo.168 Similarly, in a controlled trial, a combination of selenium, copper, and vitamins was found to be ineffective.169 It should be noted that while oral protection from sunburn has been demonstrated with several types of antioxidants, the degree of protection (typically less than an SPF of 2) is much less than that provided by currently available topical sunscreens. On the other hand, these modest effects will provide some added protection to skin areas where sunscreen is also used and will give a small amount of protection to sun-exposed areas where sunscreen is not applied. However, oral protection from sunburn is not instantaneous; maximum effects are not reached until these antioxidants have been used for about eight to ten weeks.170 , 171 |
||
| Used for | Amount | Why |
|---|---|---|
|
Sunburn
(Vitamin E) |
Refer to label instructions | |
SunburnAntioxidants may protect the skin from sunburn due to free radical–producing ultraviolet rays.172 Combinations of 1,000 to 2,000 IU per day of vitamin E and 2,000 to 3,000 mg per day of vitamin C, but neither given alone, have a significant protective effect against ultraviolet rays, according to double-blind studies.173 , 174 , 175 Oral synthetic beta-carotene alone was not found to provide effective protection when given in amounts of 15 mg per day or for only a few weeks’ time in larger amounts of 60 to 90 mg per day, but it has been effective either in very large (180 mg per day) amounts or in smaller amounts (30 mg per day) in combination with topical sunscreen.176 , 177 , 178 , 179 , 180 Natural sources of beta-carotene or other carotenoids have been more consistently shown to protect against sunburn. One controlled study found that taking a supplement of natural carotenoids (almost all of which was beta-carotene) in daily amounts of 30 mg, 60 mg, and 90 mg gave progressively more protection against ultraviolet rays.181 In another controlled study, either 24 mg per day of natural beta-carotene or 24 mg per day of a carotenoid combination of equal amounts beta-carotene, lutein, and lycopene helped protect skin from ultraviolet rays.182 A preliminary study compared synthetic lycopene (10.1 mg per day), a natural tomato extract containing 9.8 mg of lycopene per day plus additional amounts of other carotenoids, and a solubilized tomato drink (designed to increase lycopene absorption) containing 8.2 mg of lycopene plus additional amounts of other carotenoids. After 12 weeks, only the two tomato-based products were shown to give significant protection against burning by ultraviolet light.183 Still other trials have tested combinations of several antioxidants. One preliminary study found that a daily combination of beta-carotene (6 mg), lycopene (6 mg), vitamin E (15 IU), and selenium for seven weeks protected against ultraviolet light.184 However, a double-blind trial of a combination of smaller amounts of several carotenoids, vitamins C and E, selenium, and proanthocyanidins did not find significant UV protection compared with placebo.185 Similarly, in a controlled trial, a combination of selenium, copper, and vitamins was found to be ineffective.186 It should be noted that while oral protection from sunburn has been demonstrated with several types of antioxidants, the degree of protection (typically less than an SPF of 2) is much less than that provided by currently available topical sunscreens. On the other hand, these modest effects will provide some added protection to skin areas where sunscreen is also used and will give a small amount of protection to sun-exposed areas where sunscreen is not applied. However, oral protection from sunburn is not instantaneous; maximum effects are not reached until these antioxidants have been used for about eight to ten weeks.187 , 188 |
||
How It Works
How to Use It
For most people, up to 25,000 IU (7,500 mcg) of vitamin A per day is considered safe. However, people over age 65 and those with liver disease should probably not supplement with more than 15,000 IU per day, unless supervised by a doctor. In women who could become pregnant, the maximum safe intake is being re-evaluated. However, less than 10,000 IU (3,000 mcg) per day is generally accepted as safe. There is concern that larger intakes could cause birth defects. Whether the average person would benefit from vitamin A supplementation remains unclear.
Where to Find It
Liver, dairy products, and cod liver oil are good sources of vitamin A. Vitamin A is also available in supplement form.
Possible Deficiencies
People who limit their consumption of liver, dairy foods, and beta-carotene-containing vegetables can develop a vitamin A deficiency. Extremely low birth weight babies (2.2 pounds or less) are at high risk of being born with a deficiency, and vitamin A shots given to these infants have been reported in double-blind research to reduce the risk of lung disease.189 The earliest deficiency sign is poor night vision. Deficiency symptoms can also include dry skin, increased risk of infections, and metaplasia (a precancerous condition). Severe deficiencies causing blindness are extremely rare in Western societies.
Less severe deficiencies are more likely to occur with a variety of conditions causing malabsorption. A high incidence of vitamin A deficiency in people infected with HIV has also been reported. People with hypothyroidism have an impaired ability to convert beta-carotene to vitamin A.190 , 191 For this reason, some doctors suggest taking supplemental vitamin A (perhaps 5,000–10,000 IU per day) if they are not consuming adequate amounts in their diet.
Very old people with type 2 diabetes have shown a significant age-related decline in blood levels of vitamin A, irrespective of their dietary intake.192
Interactions
Interactions with Supplements, Foods, & Other Compounds
Taking vitamin A and iron together helps overcome iron deficiency more effectively than iron supplementation alone.193 Supplementation with zinc, iron, or the combination has been found to improve vitamin A status among children at high risk for deficiency of the three nutrients.194
Interactions with Medicines
Certain medicines interact with this supplement.
|
|
Some medicines may increase the need for this supplement. |
|---|---|
|
|
Some medicines interact with this supplement, so they should not be taken together. |
|
|
Some interactions between this supplement and certain medicines require more explanation. Click the link to see details. |
Note: The following list only includes the generic or class name of a medicine. To find a specific brand name, use the Medicines Index.
Side Effects
Side Effects
Since a 1995 report from the New England Journal of Medicine, 195 women who are or could become pregnant have been told by doctors to take less than 10,000 IU (3,000 mcg) per day of vitamin A to avoid the risk of birth defect. A recent report studied several hundred women exposed to 10,000–300,000 IU (median exposure of 50,000 IU) per day.196 Three major malformations occurred in this study, but all could have happened in the absence of vitamin A supplementation. Surprisingly, no congenital malformations happened in any of the 120 infants exposed to maternal intakes of vitamin A that exceeded 50,000 IU per day. In fact, the high-exposure group had a 50% decreased risk for malformations compared with infants not exposed to vitamin A. The authors noted that some previous studies found no link between vitamin A and birth defects, and argued the studies that did find such a link suffered from various weaknesses. A closer look at the recent study reveals a 32% higher than expected risk of birth defects in infants exposed to 10,000–40,000 IU of vitamin A per day, but paradoxically a 37% decreased risk for those exposed to even higher levels. This suggests that both “higher” and “lower” risks may have been due to chance.
Excessive dietary intake of vitamin A has been associated with birth defects in humans in fewer than 20 reported cases over the past 30 years.197 , 198 Presently, the level at which vitamin A supplementation may cause birth defects is not known, though combined human and animal data suggest that 30,000 IU per day should be considered safe.199 Women who are or who could become pregnant should consult with a doctor before supplementing with more than 10,000 IU per day.
Vitamin A supplements can both help and hurt children. Many people have heard that vitamin A supplements support immune function and prevent infections. This is true under some circumstances. However, vitamin A can also increase the risk of infections, according to the findings of a double-blind trial.200 In a study of African children between six months and five years old, a 44% reduction in the risk of severe diarrhea was seen in those children given four 100,000–200,000 IU applications of vitamin A (the lower amount for those less than a year old) during an eight-month period. On further investigation, the researchers discovered that the reduction in diarrhea occurred only in children who were very malnourished. For children who were not starving, vitamin A supplementation actually increased the risk of diarrhea compared with the placebo group. The vitamin A-supplemented children also had a 67% increased risk of coughing and rapid breathing, signs of further lung infection, although this problem did not appear in children infected with AIDS. These findings should be of concern to American parents, whose children are not usually infected with AIDS or severely malnourished. Such relatively healthy children fared poorly in the African trial in terms of both the risk of diarrhea and the risk of continued lung problems. Vitamin A provided no benefit to the well-nourished kids. Therefore, it makes sense to not give vitamin A supplements to children unless there is a special reason to do so, such as the presence of a condition causing malabsorption (e.g., celiac disease).
In a study of people with retinitis pigmentosa (a degenerative condition of the eye), participants received 15,000 IU of vitamin A per day for 12 years with no signs of adverse effects or toxicity.201 For other adults, intake above 25,000 IU (7,500 mcg) per day can—in rare cases—cause headaches, dry skin, hair loss, fatigue, bone problems, and liver damage.202 At higher levels (for example 100,000 IU per day) these problems become more common.
A controlled clinical trial showed that people who took 25,000 IU of vitamin A per day for a median of 3.8 years had an 11% increase in triglycerides, a 3% increase in total cholesterol and a 1% decrease in HDL cholesterol compared to those who did not take vitamin A.203 Although the significance of these findings is not clear, people at risk for cardiovascular disease should use caution when considering long-term vitamin A supplementation.
One study found that increasing the intake of vitamin A in the diet was associated with bone loss and risk of hip fracture, possibly due to a vitamin A-induced stimulation of cells that break down bone.204 In this study, a vitamin A intake greater than 5,000 IU per day, when compared to a lower intake, was associated with a reduction in bone mineral density that approximately doubles the risk of hip fracture. Beta-carotene (which can be used by the body to make vitamin A) has not been linked to reduced bone mass. Until more is known, people concerned about osteoporosis may consider taking beta-carotene supplements rather than supplementing with vitamin A.
Data from test tube, animal, and human studies show that excessive vitamin A intake can accelerate bone loss and inhibit formation of new bone, increasing the risk of osteoporosis.205 In humans, small studies have found these effects at about 85,000–125,000 IU per day. 206 , 207
References
1. Little DR. Ambulatory management of common forms of anemia. Am Fam Physician 1999;59:1598–604 [review].
2. Hodges RE, Sauberlich HE, Canham JE, et al. Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 1978;31:876–85 [review].
3. Bloem MW. Interdependence of vitamin A and iron: an important association for programmes of anaemia control. Proc Nutr Soc 1995;54:501–8 [review].
4. Lane M, Alfrey CP. The anemia of human riboflavin deficiency. Blood 1965;25:432–42.
5. Orehek AJ, Kollas CD. Refractory postpartum anemia due to vitamin B6 deficiency. Ann Intern Med 1997;126(10):834–5 [letter].
6. Iwama H, Iwase O, Hayashi S, et al. Macrocytic anemia with anisocytosis due to alcohol abuse and vitamin B6 deficiency. Rinsho Ketsueki 1998;39:1127–30 [in Japanese].
7. Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol 1999;41:895–906 [review].
8. Summerfield AL, Steinberg FU, Gonzalez JG. Morphologic findings in bone marrow precursor cells in zinc-induced copper deficiency anemia. Am J Clin Pathol 1992;97:665–8.
9. Freycon F, Pouyau G. Rare nutritional deficiency anemia: deficiency of copper and vitamin E. Sem Hop 1983;59:488–93 [review] [in French].
10. Borgna-Pignatti C, Marradi P, Pinelli L, et al. Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr 1989;114:405–10.
11. Neufeld EJ, Mandel H, Raz T, et al. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet 1997;61:1335–41.
12. Benn CS, Aaby P, Bale C, et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet 1997;350:101–5.
13. Semba RD. Vitamin A as “anti-infective” therapy, 1920–1940. J Nutr 1999;129:783–91 [review].
14. Molina EL, Patel JA. A to Z: vitamin A and zinc, the miracle duo. Indian J Pediatr 1996;63:427–31 [review].
15. Malvy D. Micronutrients and tropical viral infections: one aspect of pathogenic complexity in tropical medicine. Med Trop (Mars) 1999;59:442–8 [review; in French].
16. World Health Organization. Expanded programme on immunization: programme for the prevention of blindness nutrition. Joint WHO/UNICEF statement. Vitamin A for measles. Wkly Epidemiol Rec 1987;62:133–4.
17. Coutsoudis A, Broughton M, Coovadia HM. Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double-blind trial. Am J Clin Nutr 1991;54:890–5.
18. Rosales FJ, Kjolhede C. A single 210-mumol oral dose of retinol does not enhance the immune response in children with measles. J Nutr 1994;124:1604–14.
19. Rahmathullah L. Effect of receiving a weekly dose of vitamin A equivalent to the recommended dietary allowances among pre school children on mortality in south India. Indian J Pediatr 1991;58:837–47.
20. Vijayaraghavan K, Rashmiah G, Suryaprakasam B, et al. Effect of massive dose of vitamin A on morbidity and mortality in Indian children. Lancet 1990;336:1342–53.
21. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70 [review].
22. Frieden TR, Sowell AL, Henning JK, et al. Vitamin A levels and severity of measles: New York City. Am J Dis Child 1992;146:182–6.
23. Committee on Infectious Diseases, American Academy of Pediatrics. Vitamin A treatment of Measles. Pediatrics 1993;91:1014–5.
24. Coutsoudis A, Coovadia HM, Broughton M, et al. Micronutrient utilisation during measles treated with vitamin A or placebo. Int J Vitam Nutr Res 1991;61:199–204.
25. Campos FA, Flores H, Underwood BA. Effect of an infection on vitamin A status of children as measured by the relative dose response. Am J Clin Nutr 1987;46:91–4.
26. Ozsoylu S, Cemeroglu AP, Gunay M. Vitamin A for varicella. J Pediatr 1994;125:1017–8 [letter].
27. Turck D, Michaud L. Cystic fibrosis: nutritional consequences and management. Baillieres Clin Gastroenterol 1998;12:805–22 [review].
28. Lindemans J, Neijens HJ, Kerrebijn KF, Abels J. Vitamin B12 absorption in cystic fibrosis. Acta Paediatr Scand 1984;73:537–40.
29. Gueant JL, Vidailhet M, Pasquet C, et al. Effect of pancreatic extracts on the faecal excretion and on the serum concentration of cobalamin and cobalamin analogues in cystic fibrosis. Clin Chim Acta 1984;137:33–41.
30. Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994;19:489–99 [review].
31. Glasziou PP, Mackerras DEM. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70.
32. Stephensen CB, Franchi LM, Hernandez H, et al. Adverse effects of high-dose vitamin A supplements in children hospitalized with pneumonia. Pediatrics 1998;101(5):E3 [abstract].
33. Bresee JS, Fischer M, Dowell SF, et al. Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J 1996;15:777–82.
34. Quinlan KP, Hayani KC. Vitamin A and respiratory syncytial virus infection. Serum levels and supplementation trial. Arch Pediatr Adolesc Med 1996;150:25–30.
35. Kjolhede CL, Chew FJ, Gadomski AM, et al. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. J Pediatr 1995;126:807–12.
36. Pinnock CB, Douglas RM, Badcock NR. Vitamin A status in children who are prone to respiratory tract infections. Aust Paediatr J 1986;22:95–9.
37. Murphy S, West KP Jr, Greenough WB 3d, et al. Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age Ageing 1992;21:435–9.
38. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–7.
39. Ross AC. Vitamin A supplementation as therapy—are the benefits disease specific? Am J Clin Nutr 1998;68:8–9 [review].
40. Fawzi WW, Mbise RL, Fataki MR, et al. Vitamin A supplementation and severity of pneumonia in children admitted to the hospital in Dar es Salaam, Tanzania. Am J Clin Nutr 1998;68:187–92.
41. Stich HF, Rosin MP, Hornby AP, et al. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 1988;42:195–9.
42. Garewal HS, Katz RV, Meyskens F, et al. ß-Carotene produces sustained remission in patients with oral leukoplakia. Arch Otolaryngol Head Neck Surg 1999;125:1305–10.
43. Liede K, Hietanen J, Saxen L, et al. Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers. Oral Dis 1998;4:78–83.
44. Toma S, Benso S, Albanese E, et al. Treatment of oral leukoplakia with beta-carotene. Oncology 1992;49:77–81.
45. Garewal HS, Meyskens FL Jr, Killen D, et al. Response of oral leukoplakia to beta-carotene. J Clin Oncol 1990;8:1715–20.
46. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993;328:15–20.
47. Johnson J, Ringsdorf W, Cheraskin E. Relationship of vitamin A and oral leukoplakia. Arch Derm 1963;88:607–12.
48. Stich HF, Mathews B, Sankaranarayanan R, Nair MK. Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of ß-carotene or vitamin A. Am J Clin Nutr 1991;53:298S–304S.
49. Stich HF, Rosin MP, Hornby AP, et al. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 1988;42:195–9.
50. Rumore MM. Vitamin A as an immunomodulating agent. Clin Pharm 1993;12:506–14 [review].
51. West CE. Vitamin A and measles. Nutr Rev 2000;58:S46–S54.
52. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70.
53. Markowitz LE, Nzilambi N, Driskell WJ, et al. Vitamin A levels and mortality among hospitalized measles patients, Kinshasa, Zaire. J Trop Pediatr 1989;35:109–12.
54. Arrieta AC, Zaleska M, Stutman HR, Marks MI. Vitamin A levels in children with measles in Long Beach, California. J Pediatr 1992;121:75–8.
55. Butler JC, Havens PL, Sowell AL, et al. Measles severity and serum retinol (vitamin A) concentration among children in the United States. Pediatrics 1993;91:1176–81.
56. Frieden TR, Sowell AL, Henning KJ, et al. Vitamin A levels and severity of measles. New York City. Am J Dis Child 1992;146:182–6.
57. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70.
58. Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA 1993;269:898–903.
59. Barclay AJ, Foster A, Sommer A. Vitamin A supplements and mortality related to measles: a randomised clinical trial. BMJ 1987;294:294–6.
60. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70.
61. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990;323:160–4.
62. Kawasaki Y, Hosoya M, Katayose M, Suzuki H. The efficacy of oral vitamin A supplementation for measles and respiratory syncytial virus (RSV) infection. Kansenshogaku Zasshi 1999;73:104–9 [in Japanese].
63. Ellison JB. Intensive vitamin A therapy in measles. BMJ 1932;2:708–11.
64. Russell RM, Smith VC, Multak R, et al. Dark-adaptation testing for diagnosis of subclinical vitamin-A deficiency and evaluation of therapy. Lancet 1973;2:1161–4.
65. Singh RB, Niaz MA, Sharma JP, et al. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardiol 1994;49:441–52.
66. Levy Y, Bartha P, Ben-Amotz A, et al. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombolysis. J Am Coll Nutr 1998;17:337–41.
67. Singh RB, Niaz MA, Rastogi SS, Tastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am J Cardiol 1996;77:232–6.
68. Kardinaal AFM, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379–84.
69. Tavani A, Negri E, D’Avanzo B, La Vecchia C. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women. Eur J Epidemiol 1997;13:631–7.
70. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715–20.
71. Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668–75.
72. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:261–6.
73. Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994;19:489–99 [review].
74. Glasziou PP, Mackerras DEM. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70.
75. Stephensen CB, Franchi LM, Hernandez H, et al. Adverse effects of high-dose vitamin A supplements in children hospitalized with pneumonia. Pediatrics 1998;101(5):E3 [abstract].
76. Bresee JS, Fischer M, Dowell SF, et al. Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J 1996;15:777–82.
77. Quinlan KP, Hayani KC. Vitamin A and respiratory syncytial virus infection. Serum levels and supplementation trial. Arch Pediatr Adolesc Med 1996;150:25–30.
78. Kjolhede CL, Chew FJ, Gadomski AM, et al. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. J Pediatr 1995;126:807–12.
79. Pinnock CB, Douglas RM, Badcock NR. Vitamin A status in children who are prone to respiratory tract infections. Aust Paediatr J 1986;22:95–9.
80. Murphy S, West KP Jr, Greenough WB 3d, et al. Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age Ageing 1992;21:435–9.
81. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–7.
82. Ross AC. Vitamin A supplementation as therapy--are the benefits disease specific? Am J Clin Nutr 1998;68:8–9 [review].
83. Fawzi WW, Mbise RL, Fataki MR, et al. Vitamin A supplementation and severity of pneumonia in children admitted to the hospital in Dar es Salaam, Tanzania. Am J Clin Nutr 1998;68:187–92.
84. American Academy of Pediatrics Committee on Infectious Diseases. Vitamin A treatment of measles. Pediatrics 1993,91:1014–5.
85. Penn ND, Purkins L, Kelleher J, et al. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 1991;20:169–74.
86. de la Fuente M, Ferrandez MD, Burgos MS, et al. Immune function in aged women is improved by ingestion of vitamins C and E. Can J Physiol Pharmacol 1998;76:373–80.
87. Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia. S Afr Med J 1977;51:191–3.
88. Patty I, Benedek S, Deak G, et al. Controlled trial of vitamin A therapy in gastric ulcer. Lancet 1982;2(8303):876 [letter].
89. Patty I, Tarnok F, Simon L, et al. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study). Acta Physiol Hung 1984;64:379–84.
90. Molina EL, Patel JA. A to Z: vitamin A and zinc, the miracle duo. Indian J Pediatr 1996;63:427–31 [review].
91. Malvy D. Micronutrients and tropical viral infections: one aspect of pathogenic complexity in tropical medicine. Med Trop (Mars) 1999;59:442–8 [review; in French].
92. World Health Organization. Expanded programme on immunization: programme for the prevention of blindness nutrition. Joint WHO/UNICEF statement. Vitamin A for measles. Wkly Epidemiol Rec 1987;62:133–4.
93. Coutsoudis A, Broughton M, Coovadia HM. Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double-blind trial. Am J Clin Nutr 1991;54:890–5.
94. Rosales FJ, Kjolhede C. A single 210-mumol oral dose of retinol does not enhance the immune response in children with measles. J Nutr 1994;124:1604–14.
95. Rahmathullah L. Effect of receiving a weekly dose of vitamin A equivalent to the recommended dietary allowances among pre school children on mortality in south India. Indian J Pediatr 1991;58:837–47.
96. Vijayaraghavan K, Rashmiah G, Suryaprakasam B, et al. Effect of massive dose of vitamin A on morbidity and mortality in Indian children. Lancet 1990;336:1342–53.
97. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993;306:366–70 [review].
98. Frieden TR, Sowell AL, Henning JK, et al. Vitamin A levels and severity of measles: New York City. Am J Dis Child 1992;146:182–6.
99. Committee on Infectious Diseases, American Academy of Pediatrics. Vitamin A treatment of Measles. Pediatrics 1993;91:1014–5.
100. Coutsoudis A, Coovadia HM, Broughton M, et al. Micronutrient utilisation during measles treated with vitamin A or placebo. Int J Vitam Nutr Res 1991;61:199–204.
101. Campos FA, Flores H, Underwood BA. Effect of an infection on vitamin A status of children as measured by the relative dose response. Am J Clin Nutr 1987;46:91–4.
102. Ozsoylu S, Cemeroglu AP, Gunay M. Vitamin A for varicella. J Pediatr 1994;125:1017–8 [letter].
103. Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986;15:817–21 [review].
104. Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986;15:817–21 [review].
105. Hunt TK, Ehrlich HP, Garcia JA, et al. Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man. Ann Surg 1969;170:633–41.
106. Romney SL, Palan PR, Duttagupta C, et al. Retinoids and the prevention of cervical dysplasias. Am J Obstet Gynecol 1981;141:890–4.
107. Kligman AM, Mills OH Jr, Leyden JJ, et al. Oral vitamin A in acne vulgaris. Preliminary report. Int J Dermatol 1981;20:278–85.
108. Morgan MY, Levine JA. Alcohol and nutrition. Proc Natl Acad Sci 1988;47:85–98.
109. Chapman K, Prabhudesai M, Erdman JW. Vitamin A status of alcoholics upon admission and after two weeks of hospitalization. J Am Coll Nutr 1993;12:77–83.
110. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999;69:1071–85 [review].
111. Chen M, Boyce W, Hsu JM. Effect of ascorbic acid on plasma alcohol clearance. J Am Coll Nutr 1990;9:185–9.
112. Rankov BG. Vitamin A and carotene concentration in serum in persons with chronic conjunctivitis and pterygium. Int J Vitam Nutr Res 1976;46:454–7 [in German].
113. Dvorak AM. Vitamin A in Crohn’s disease. Lancet 1980;i:1303–4.
114. Skogh M, Sundquist T, Tagesson C. Vitamin A in Crohn’s disease. Lancet 1980; i:766 [letter].
115. Dvorak AM. Vitamin A in Crohn’s Disease. Lancet 1980;i:1303–4 [letter].
116. Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy inpatients with Crohn’s disease. Gastroenterology 1985;88:512–4.
117. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–7.
118. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;22(21):793–6.
119. Keyvani F, Yassai M, Kimiagar M. Vitamin A status and endemic goiter. Int J Vitam Nutr Res 1988;58:155–60.
120. Mesaros-Kanjski E, Kontosic I, Kusic Z, et al. Endemic goitre and plasmatic levels of vitamins A and E in the school-children on the island of Krk, Croatia. Coll Antropol 1999;23:729–36.
121. Mesaros-Kanjski E, Kontosic I, Kusic Z, et al. Endemic goitre and plasmatic levels of vitamins A and E in the school-children on the island of Krk, Croatia. Coll Antropol 1999;23:729–36.
122. Mutaku JF, Many MC, Colin I, et al. Antigoitrogenic effect of combined supplementation with dl-alpha-tocopherol, ascorbic acid and beta-carotene and of dl-alpha-tocopherol alone in the rat. J Endocrinol 1998;156:551–61.
123. Semba RD, Graham NMH, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993;153:2149–54.
124. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593–7.
125. Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999;13:1517–24.
126. Kennedy CM, Coutsoudis A, Kuhn L, et al. Randomized controlled trial assessing the effect of vitamin A supplementation on maternal morbidity during pregnancy and postpartum among HIV-infected women. J Acquir Immune Defic Syndr 2000;24:37–44.
127. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246–54.
128. Coutsoudis A, Bobat RA, Coovadia HM, et al. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995;85:1076–81.
129. Hanekom WA, Yogev R, Heald LM, et al. Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus. J Pediatr 2000;136:550–2.
130. Humphrey JH, Quinn T, Fine D, et al. Short-term effects of large-dose vitamin A supplementation on viral load and immune response in HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:44–51.
131. Smolle J, Wawschinek O, Hayn H, Eber O. Vitamin A and carotene in thyroid disease. Acta Med Austriaca 1983;10:71–3 [in German].
132. Aktuna D, Buchinger W, Langsteger W, et al. Beta-carotene, vitamin A and carrier proteins in thyroid diseases. Acta Med Austriaca 1993;20:17–20 [in German].
133. Mazzotta MY. Nutrition and wound healing. J Am Podiatr Med Assoc 1994;84:456–62 [review].
134. Swartz-Basile DA, Rubin DC, Levin MS. Vitamin A status modulates intestinal adaptation after partial small bowel resection. JPEN J Parenter Enteral Nutr 2000;24:81–8.
135. Ehrlich H, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968;167:324–8.
136. Hunt TK, Ehrlich HP, Garcia JA, Dunphy JE. Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man. Ann Surg 1969;170:633–40.
137. Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg 1973;177:222–7.
138. Hunt TK, Ehrlich HP, Garcia JA, Dunphy JE. Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man. Ann Surg 1969;170:633–40.
139. Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986;15:817–21.
140. Block E. The use of vitamin A in premenstrual tension. Acta Obstet Gynecol Scand 1960;39:586–92.
141. Argonz J, Abinzano C. Premenstrual tension treated with vitamin A. J Clin Endocrinol 1950;10:1579–89.
142. Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol 1989;32:161–6.
143. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
144. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and carotenoid levels in sickle cell disease patients. Am J Med Sci 1990;229:13–5.
145. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vitro. Clin Chim Acta 1985;149:257–61.
146. Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, Bowen P. Low serum levels of carotenoids in sickle cell anemia. Eur J Haematol 1988;41:131–5.
147. Essein, EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia. Centr Afr J Med 1995;41:48–50.
148. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anemia. East Afr Med J 1990;67:720–5.
149. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia. Am J Hematol 1992;41:227–31.
150. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr 1980;33:968–71.
151. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
152. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
153. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
154. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990;323:160–4.
155. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848–73.
156. Werninghaus K, Meydani M, Bhawan J, et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol 1994;130:1257–61.
157. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med 1998;25:1006–12.
158. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998;38:45–8.
159. McArdle F, Rhodes LE, Parslew RA, et al. Effects of oral vitamin E and beta-carotene supplementation on ultraviolet radiation-induced oxidative stress in human skin. Am J Clin Nutr 2004;80:1270–5.
160. Garmyn M, Ribaya-Mercado JD, Russel RM, et al. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol 1995;4:104–11.
161. Wolf C, Steiner A, Honigsmann H, et al. Do oral carotenoids protect human skin against UV erythema, psoralen phototoxicity, and UV-induced DNA damage? J Invest Dermatol 1988;90:55–57.
162. Mathews-Roth MM, Pathak MA, Parrish J, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol 1972;59:349–53.
163. Gollnick HP, Hopfenmuller W, Hemmes C, et al. Systemic B-carotene plus topical sunscreen are an optimal protection against harmful effects of natural UV-sunlight. Eur J Dermatol 1996;6:200–5.
164. Lee J, Jiang S, Levine N, Watson RR. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med 2000;223:170–4.
165. Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr 2003;133:98–101.
166. Aust O, Stahl W, Sies H, et al. Supplementation with tomato-based products increases lycopene, phytofluene, and phytoene levels in human serum and protects against UV-light-induced erythema. Int J Vitam Nutr Res 2005;75:54–60.
167. Cesarini JP, Michel L, Maurette JM, et al. Immediate effects of UV radiation on the skin: modification by an antioxidant complex containing carotenoids. Photodermatol Photoimmunol Photomed 2003;19:182–9.
168. Greul AK, Grundmann JU, Heinrich F, et al. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol 2002;15:307–15.
169. La Ruche G, Cesarini JP. Protective effect of oral selenium plus copper associated with vitamin complex on sunburn cell formation in human skin. Photodermatol Photoimmunol Photomed 1991;8:232–5.
170. Sies H, Stahl W. Nutritional protection against skin damage from sunlight. Annu Rev Nutr 2004;24:173–200 [review].
171. Sies H, Stahl W. Carotenoids and UV protection. Photochem Photobiol Sci 2004;3:749-52 [review].
172. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848–73.
173. Werninghaus K, Meydani M, Bhawan J, et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol 1994;130:1257–61.
174. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med 1998;25:1006–12.
175. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998;38:45–8.
176. McArdle F, Rhodes LE, Parslew RA, et al. Effects of oral vitamin E and beta-carotene supplementation on ultraviolet radiation-induced oxidative stress in human skin. Am J Clin Nutr 2004;80:1270–5.
177. Garmyn M, Ribaya-Mercado JD, Russel RM, et al. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol 1995;4:104–11.
178. Wolf C, Steiner A, Honigsmann H, et al. Do oral carotenoids protect human skin against UV erythema, psoralen phototoxicity, and UV-induced DNA damage? J Invest Dermatol 1988;90:55–57.
179. Mathews-Roth MM, Pathak MA, Parrish J, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol 1972;59:349–53.
180. Gollnick HP, Hopfenmuller W, Hemmes C, et al. Systemic B-carotene plus topical sunscreen are an optimal protection against harmful effects of natural UV-sunlight. Eur J Dermatol 1996;6:200–5.
181. Lee J, Jiang S, Levine N, Watson RR. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med 2000;223:170–4.
182. Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr 2003;133:98–101.
183. Aust O, Stahl W, Sies H, et al. Supplementation with tomato-based products increases lycopene, phytofluene, and phytoene levels in human serum and protects against UV-light-induced erythema. Int J Vitam Nutr Res 2005;75:54–60.
184. Cesarini JP, Michel L, Maurette JM, et al. Immediate effects of UV radiation on the skin: modification by an antioxidant complex containing carotenoids. Photodermatol Photoimmunol Photomed 2003;19:182–9.
185. Greul AK, Grundmann JU, Heinrich F, et al. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol 2002;15:307–15.
186. La Ruche G, Cesarini JP. Protective effect of oral selenium plus copper associated with vitamin complex on sunburn cell formation in human skin. Photodermatol Photoimmunol Photomed 1991;8:232–5.
187. Sies H, Stahl W. Nutritional protection against skin damage from sunlight. Annu Rev Nutr 2004;24:173–200 [review].
188. Sies H, Stahl W. Carotenoids and UV protection. Photochem Photobiol Sci 2004;3:749-52 [review].
189. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 1999;340:1962–8.
190. Smolle J, Wawschinek O, Hayn H, Eber O. Vitamin A and carotene in thyroid disease. Acta Med Austriaca 1983;10:71–3 [in German].
191. Aktuna D, Buchinger W, Langsteger W, et al. Beta-carotene, vitamin A and carrier proteins in thyroid diseases. Acta Med Austriaca 1993;20:17–20 [in German].
192. Polidori MC, Mecocci P, Stahl W, et al. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev 2000;16:15–9.
193. Mejia LA, Chew F. Hematological effect of supplementing anemic children with vitamin A alone and in combination with iron. Am J Clin Nutr 1988;48:595–600.
194. Muñoz EC, Rosado JL, Lopez P, et al. Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers. Am J Clin Nutr 2000;71:789–94.
195. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369–73.
196. Mastroiacovo P, Mazzone T, Addis A, et al. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999;59:7–11.
197. Biesalski HK. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 1989;57:117–61.
198. Azais-Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J Clin Nutr 2000;71(5 Suppl):1325S–33S [review].
199. Wiegand UW, Hartmann S, Hummler H. Safety of vitamin A: recent results. Int J Vitam Nutr Res 1998;68:411–6 [review].
200. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–7.
201. Sibulesky L, Hayes KC, Pronczuk A, et al. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 1999;69:656–63.
202. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358–71.
203. Cartmel B, Moon TE, Levine N. Effects of long-term intake of retinol on selected clinical and laboratory indexes. Am J Clin Nutr 1999;69:937–43.
204. Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Int Med 1998;129:770–8.
205. Binkley N, Krueger D. Hypervitaminosis A and bone. Nutr Rev 2000;58:138–44 [review].
206. Frame B, Jackson CE, Reynolds WA, Umphrey JE. Hypercalcemia and skeletal effects in chronic hypervitaminosis A. Ann Intern Med 1974;80:44–8.
207. Patel P, Hanning RM, Atkinson SA, et al. Intoxication from vitamin A in an asthmatic child. CMAJ 1988;139:755–6.
Last Review: 08-17-2011
Copyright © 2011 Aisle7. All rights reserved. www.Aisle7.net
Learn more about Aisle7, the company.
The information presented in Aisle7 is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires June 2013.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
